Production (Stage)
PureTech Health plc
PRTC
$18.20
-$0.80-4.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 44.98% | -64.85% | -96.01% | -86.12% | -78.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.98% | -64.85% | -96.01% | -86.12% | -78.68% |
| Cost of Revenue | -27.11% | -30.55% | -33.26% | -35.73% | -37.69% |
| Gross Profit | 29.73% | 27.98% | 26.52% | 30.13% | 33.02% |
| SG&A Expenses | 34.10% | 8.17% | -13.58% | -13.11% | -12.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.11% | -16.96% | -26.49% | -28.65% | -30.53% |
| Operating Income | 6.26% | 14.69% | 21.76% | 24.41% | 26.73% |
| Income Before Tax | 165.85% | 38.14% | -53.04% | 20.83% | 61.09% |
| Income Tax Expenses | -113.13% | -55.16% | 210.01% | 164.18% | 154.78% |
| Earnings from Continuing Operations | 141.70% | 41.21% | -129.83% | -105.48% | -79.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2,663.48% | 578.66% | 195.22% | 139.82% | 107.01% |
| Net Income | 181.45% | 74.31% | -75.41% | -52.17% | -30.47% |
| EBIT | 6.26% | 14.69% | 21.76% | 24.41% | 26.73% |
| EBITDA | 5.09% | 14.06% | 21.73% | 24.54% | 27.00% |
| EPS Basic | 202.10% | 85.18% | -80.60% | -57.08% | -34.73% |
| Normalized Basic EPS | 47.85% | 13.52% | -37.99% | -56.89% | -79.30% |
| EPS Diluted | 197.17% | 82.50% | -79.86% | -56.12% | -33.70% |
| Normalized Diluted EPS | 48.06% | 13.64% | -37.99% | -56.89% | -79.30% |
| Average Basic Shares Outstanding | -7.91% | -5.37% | -2.86% | -2.91% | -2.97% |
| Average Diluted Shares Outstanding | -7.34% | -5.08% | -2.86% | -2.91% | -2.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |